G
Geoffrey C. Gurtner
Researcher at Stanford University
Publications - 478
Citations - 32002
Geoffrey C. Gurtner is an academic researcher from Stanford University. The author has contributed to research in topics: Wound healing & Medicine. The author has an hindex of 76, co-authored 423 publications receiving 25985 citations. Previous affiliations of Geoffrey C. Gurtner include Duke University & York University.
Papers
More filters
Journal ArticleDOI
Endostatin inhibits ischemia-induced neovascularization and increases ischemic tissue loss.
Michael Dobryansky,Robert D. Galiano,Curtis L. Cetrulo,Kirit A. Bhatt,Joseph Michaels,Russell L. Ashinoff,Jamie P. Levine,Geoffrey C. Gurtner +7 more
TL;DR: It is found that endostatin significantly decreased flap survival and has potential implications for the patients undergoing antiangiogenesis therapy who require surgical reconstruction.
Journal ArticleDOI
PHD-2 Suppression in Mesenchymal Stromal Cells Enhances Wound Healing.
Sae Hee Ko,Allison Nauta,Shane D. Morrison,Michael S. Hu,A.S. Zimmermann,Michael T. Chung,Jason P. Glotzbach,Victor W. Wong,G G Walmsley,H. Peter Lorenz,Denise A. Chan,Geoffrey C. Gurtner,Amato J. Giaccia,Michael T. Longaker +13 more
TL;DR: Silencing PHD-2 in mesenchymal stromal cells augments their proangiogenic potential in wound healing therapy and appears to be mediated by overexpression of HIF family transcription factors and up-regulation of multiple downstream angiogenic factors.
Journal ArticleDOI
Is early inflammation good or bad? Linking early immune changes to hypertrophic scarring.
TL;DR: A new study revisited this topic and demonstrated that reduced and/or delayed early immunological responses were actually associated with HTS formation.
Journal ArticleDOI
Stem cells: Update and impact on craniofacial surgery
Benjamin Levi,Jason P. Glotzbach,Victor W. Wong,Emily R. Nelson,Jeong S. Hyun,Derrick C. Wan,Geoffrey C. Gurtner,Michael T. Longaker +7 more
TL;DR: The current clinical need for skeletal and soft tissue engineering faced by craniofacial surgeons is discussed, cell types and scaffold designs being used for tissue-engineering treatment options are explored, and ways to enhance the vascularity of tissue-engineered constructs are discussed.
Journal ArticleDOI
Xenogeneic skin transplantation promotes angiogenesis and tissue regeneration through activated Trem2+ macrophages.
Dominic Henn,Dominic Henn,Kellen Chen,Tobias Fehlmann,Artem A. Trotsyuk,Dharshan Sivaraj,Zeshaan N. Maan,Clark A. Bonham,Janos A. Barrera,Chyna J. Mays,Autumn H. Greco,Sylvia E. Moortgat Illouz,John Q. Lin,Sydney R. Steele,Deshka S. Foster,Jagannath Padmanabhan,Arash Momeni,Dung Nguyen,Derrick C. Wan,Ulrich Kneser,Michael Januszyk,Andreas Keller,Andreas Keller,Michael T. Longaker,Geoffrey C. Gurtner +24 more